301 related articles for article (PubMed ID: 27152848)
1. Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.
Bissonnette R; Suárez-Fariñas M; Li X; Bonifacio KM; Brodmerkel C; Fuentes-Duculan J; Krueger JG
PLoS One; 2016; 11(5):e0155215. PubMed ID: 27152848
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
[TBL] [Abstract][Full Text] [Related]
3. Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.
Kim TH; Kim JS; Kwon JE; Park B; Lee ES
Ann Dermatol; 2022 Feb; 34(1):7-13. PubMed ID: 35221589
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis.
Wang CQ; Haxhinasto S; Garcet S; Kunjravia N; Cueto I; Gonzalez J; Rambhia D; Harari O; Sleeman MA; Hamilton JD; Lim WK; Freudenberg J; Kalliolias GD; Thakker P; Bissonnette R; Krueger JG
J Invest Dermatol; 2023 Jan; 143(1):87-97.e14. PubMed ID: 35934055
[TBL] [Abstract][Full Text] [Related]
6. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway.
Bissonnette R; Fuentes-Duculan J; Mashiko S; Li X; Bonifacio KM; Cueto I; Suárez-Fariñas M; Maari C; Bolduc C; Nigen S; Sarfati M; Krueger JG
J Dermatol Sci; 2017 Jan; 85(1):20-26. PubMed ID: 27743912
[TBL] [Abstract][Full Text] [Related]
7. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
[TBL] [Abstract][Full Text] [Related]
8. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
Yamamoto T
J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
Morales-Múnera C; Vilarrasa E; Puig L
Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
[TBL] [Abstract][Full Text] [Related]
10. Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.
Liang Y; Xing X; Beamer MA; Swindell WR; Sarkar MK; Roberts LW; Voorhees JJ; Kahlenberg JM; Harms PW; Johnston A; Gudjonsson JE
J Allergy Clin Immunol; 2017 Apr; 139(4):1217-1227. PubMed ID: 27884600
[TBL] [Abstract][Full Text] [Related]
11. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
[TBL] [Abstract][Full Text] [Related]
12. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in palmoplantar pustulosis.
Brunasso AMG; Massone C
Fac Rev; 2021; 10():62. PubMed ID: 34409425
[TBL] [Abstract][Full Text] [Related]
14. Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion.
Sevrain M; Richard MA; Barnetche T; Rouzaud M; Villani AP; Paul C; Beylot-Barry M; Jullien D; Aractingi S; Aubin F; Joly P; Le Maitre M; Cantagrel A; Ortonne JP; Misery L
J Eur Acad Dermatol Venereol; 2014 Aug; 28 Suppl 5():13-6. PubMed ID: 24985558
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
Yamamoto T
Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
[TBL] [Abstract][Full Text] [Related]
17. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
[TBL] [Abstract][Full Text] [Related]
18. What do we know about palmoplantar pustulosis?
Misiak-Galazka M; Wolska H; Rudnicka L
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
[TBL] [Abstract][Full Text] [Related]
19. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
Murakami M; Terui T
J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
[TBL] [Abstract][Full Text] [Related]
20. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.
Assan F; Husson B; Hegazy S; Seneschal J; Aubin F; Mahé E; Jullien D; Sbidian E; D'Incan M; Conrad C; Brenaut E; Girard C; Richard MA; Bachelez H; Viguier M;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1578-1583. PubMed ID: 35366356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
